This heightened presence is largely attributed to the elevated expression of m6A methyltransferases METTL3 and METTL14 and their cofactors within ESCC cells, all of which synergistically contribute to the m6A modification of RNA. The gene discussed is METTL14; the disease is esophageal squamous cell carcinoma.